Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62010CA0011

Case C-11/10: Judgment of the Court (Fifth Chamber) of 17 February 2011 (reference for a preliminary ruling from the Hoge Raad der Nederlanden (Netherlands)) — Staatssecretaris van Financiën v Marishipping and Transport BV (Reference for a preliminary ruling — Regulation (EEC) No 2658/87 — Common Customs Tariff — Customs duties — Relief — Pharmaceutical substances — Composition — Restrictions)

IO C 103, 2.4.2011, p. 7–7 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

2.4.2011   

EN

Official Journal of the European Union

C 103/7


Judgment of the Court (Fifth Chamber) of 17 February 2011 (reference for a preliminary ruling from the Hoge Raad der Nederlanden (Netherlands)) — Staatssecretaris van Financiën v Marishipping and Transport BV

(Case C-11/10) (1)

(Reference for a preliminary ruling - Regulation (EEC) No 2658/87 - Common Customs Tariff - Customs duties - Relief - Pharmaceutical substances - Composition - Restrictions)

2011/C 103/10

Language of the case: Dutch

Referring court

Hoge Raad der Nederlanden

Parties to the main proceedings

Applicant: Staatssecretaris van Financiën

Defendant: Marishipping and Transport BV

Re:

Reference for a preliminary ruling from the Hoge Raad der Nederlanden (Netherlands) — Interpretation of Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff (OJ 1987 L 256, p. 1) — Pharmaceutical substances exempted from customs duties — Substance not presented in its pure form — Restrictions

Operative part of the judgment

Part One, Section II, C, 1(i) of Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff, as amended by Commission Regulations (EC) Nos 2031/2001 of 6 August 2001 and 1832/2002 of 1 August 2002, must be interpreted as meaning that a pharmaceutical substance listed in Annex 3 of Part Three of Annex I, to which other substances have been added, in particular pharmaceutical substances, no longer qualifies for the duty-free treatment which would have applied if such a substance had been in its pure form.


(1)  OJ C 80, 27.3.2010.


Top